Thirty-seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, L-Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patie
High-dose methotrexate in the treatment of adult acute lymphoblastic leukemia
✍ Scribed by N. Gökbuget; D. Hoelzer
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 192 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Tromboembolic and hemorrhagic complications are significant causes of death in patients with malignancy. These are well‐known with the use of certain drugs. This study was planned to investigate whether there was any effect of high‐dose methotrexate on the hemostatic syst
The pilot study using HDM in all cases of ALL in childhood had been run for 4 112 years as of September 1985. Fourteen (23%) of all 62 diagnosed cases of ALL had WBC above 50 x 109/L, all 14 achieved CR. Three of them were below one year of age, two also had WBC above 400 x 109/L, the third infant h
Recent treatment strategies in adult ALL mainly include (1) intensification of induction and consolidation chemotherapy, (2) molecular targeting, particularly in Ph/bcr abl pos-ALL, (3) antibody therapy and (4) extension of stem cell transplantation (SCT). New diagnostic tools are used to refine def
Six adults with refractory acute lymphocytic leukemia (ALL) were treated with high-dose methotrexate, citrovorum factor, and vincristine. All patients had previously received extensive treatment with standard therapeutic agents, including vincristine, and all but one had received prior methotrexate.